{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:29:31Z","timestamp":1740547771844,"version":"3.38.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,25]]},"DOI":"10.7759\/cureus.79631","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:42:19Z","timestamp":1740501739000},"source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic Anti-transcriptional Intermediary Factor 1\u03b3 (Anti-TIF1\u03b3)-Positive Dermatomyositis Presenting as Dropped Head Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Areti","family":"Kalfoutzou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Toilos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleopatra","family":"Rapti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Manoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Kouremenos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Chaleplidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asimina","family":"Restemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftheria","family":"Bagiokou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Ramfidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15128","article-title":"Anti-transcriptional intermediary factor 1-\u03b3 antibody as a biomarker in patients with dermatomyositis","volume":"47","author":"Shimizu K","year":"2020","unstructured":"Shimizu K, Kobayashi T, Kano M, Hamaguchi Y, Takehara K, Matsushita T. Anti-transcriptional intermediary factor 1-\u03b3 antibody as a biomarker in patients with dermatomyositis. J Dermatol. 2020, 47:64-8. 10.1111\/1346-8138.15128","journal-title":"J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01570-y","article-title":"Anti-TIF1 gamma-positive IPAF patient developed stage IVB lung squamous carcinoma in 1 year: a case report","volume":"21","author":"Xie JJ","year":"2021","unstructured":"Xie JJ, Li B, Xu R, Du XZ, He JZ. Anti-TIF1 gamma-positive IPAF patient developed stage IVB lung squamous carcinoma in 1 year: a case report. BMC Pulm Med. 2021, 21:204. 10.1186\/s12890-021-01570-y","journal-title":"BMC Pulm Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22978","article-title":"The role of myositis-specific autoantibodies in the dermatomyositis spectrum","volume":"14","author":"Marasandra Ramesh H","year":"2022","unstructured":"Marasandra Ramesh H, Gude SS, Venugopal S, et al.. The role of myositis-specific autoantibodies in the dermatomyositis spectrum. Cureus. 2022, 14:e22978. 10.7759\/cureus.22978","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2021.100217","article-title":"SCLC, paraneoplastic dermatomyositis, positive transcription intermediary factor 1-\u03b3, and point mutation in the transcription intermediary factor 1-\u03b3 coding gene: a case report","volume":"2","author":"Arnon J","year":"2021","unstructured":"Arnon J, Elia A, Nevo Y, Lossos A, Nechushtan H. SCLC, paraneoplastic dermatomyositis, positive transcription intermediary factor 1-\u03b3, and point mutation in the transcription intermediary factor 1-\u03b3 coding gene: a case report. JTO Clin Res Rep. 2021, 2:100217. 10.1016\/j.jtocrr.2021.100217","journal-title":"JTO Clin Res Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2867","article-title":"Pustulosis acuta generalisata with mucosal and joint involvement associated with polyspecific autoantibodies","volume":"26","author":"Bal\u00e1zs A","year":"2016","unstructured":"Bal\u00e1zs A, K\u00e1lm\u00e1n E, Gy\u00f6m\u00f6rei C, Gyulai R, Kiny\u00f3 \u00c1. Pustulosis acuta generalisata with mucosal and joint involvement associated with polyspecific autoantibodies. Eur J Dermatol. 2016, 26:624-6. 10.1684\/ejd.2016.2867","journal-title":"Eur J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-022-08922-4","article-title":"Autoantibody markers of increased risk of malignancy in patients with dermatomyositis","volume":"63","author":"Marz\u0119cka M","year":"2022","unstructured":"Marz\u0119cka M, Niemczyk A, Rudnicka L. Autoantibody markers of increased risk of malignancy in patients with dermatomyositis. Clin Rev Allergy Immunol. 2022, 63:289-96. 10.1007\/s12016-022-08922-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8837463","article-title":"A case report of anti-TIF1-\u03b3 antibody-positive dermatomyositis concomitant with small cell neuroendocrine carcinoma of the urinary bladder","volume":"2023","author":"Hounoki H","year":"2023","unstructured":"Hounoki H, Onose T, Yamazaki M, et al.. A case report of anti-TIF1-\u03b3 antibody-positive dermatomyositis concomitant with small cell neuroendocrine carcinoma of the urinary bladder. Case Rep Rheumatol. 2023, 2023:8837463. 10.1155\/2023\/8837463","journal-title":"Case Rep Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002863","article-title":"Anti-TIF1-\u03b3 antibody and cancer-associated myositis: a clinicohistopathologic study","volume":"87","author":"Hida A","year":"2016","unstructured":"Hida A, Yamashita T, Hosono Y, et al.. Anti-TIF1-\u03b3 antibody and cancer-associated myositis: a clinicohistopathologic study. Neurology. 2016, 87:299-308. 10.1212\/WNL.0000000000002863","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2020.1789302","article-title":"Presence of anti-transcriptional intermediary factor-1 gamma antibodies in a dermatomyositis patient with retroperitoneal cancer of unknown primary site","volume":"5","author":"Hori H","year":"2021","unstructured":"Hori H, Ozeki Y, Kobashigawa T, et al.. Presence of anti-transcriptional intermediary factor-1 gamma antibodies in a dermatomyositis patient with retroperitoneal cancer of unknown primary site. Mod Rheumatol Case Rep. 2021, 5:62-8. 10.1080\/24725625.2020.1789302","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-233385","article-title":"Dropped head syndrome as initial and predominant manifestation of inflammatory myopathy","volume":"14","author":"Ivanovski T","year":"2021","unstructured":"Ivanovski T, D\u00e1vila Gonz\u00e1lez P, Oliv\u00e9 Plana M, Miralles Morell F. Dropped head syndrome as initial and predominant manifestation of inflammatory myopathy. BMJ Case Rep. 2021, 14:233385.","journal-title":"BMJ Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S231195","article-title":"Myositis specific autoantibodies: a clinical perspective","volume":"12","author":"Alenzi F","year":"2020","unstructured":"Alenzi F. Myositis specific autoantibodies: a clinical perspective. Open Access Rheumatol. 2020, 12:9-14. 10.2147\/OARRR.S231195","journal-title":"Open Access Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010111","article-title":"Update on malignancy in myositis-well-established association with unmet needs","volume":"12","author":"Opinc AH","year":"2022","unstructured":"Opinc AH, Makowska JS. Update on malignancy in myositis-well-established association with unmet needs. Biomolecules. 2022, 12:111. 10.3390\/biom12010111","journal-title":"Biomolecules"},{"key":"ref13","article-title":"Anti-TIF1-\u03b3 antibody-positive dermatomyositis caused by camrelizumab in a patient with oesophageal cancer","volume":"41","author":"Li J","year":"2023","unstructured":"Li J, Yi S, Huang Y, Peng Y, Yang Z. Anti-TIF1-\u03b3 antibody-positive dermatomyositis caused by camrelizumab in a patient with oesophageal cancer. Clin Exp Rheumatol [Internet]. 2023, 41:395.","journal-title":"Clin Exp Rheumatol [Internet]"},{"key":"ref14","article-title":"Anti-TIF1\u03b3-dermatomyositis and Sj\u00f6gren\u2019s syndrome as rectal cancer inaugural presentation","volume":"16","author":"Oliveira Santos M","year":"2024","unstructured":"Oliveira Santos M, Santos I, Sacramento G, Oliveira R, Castanheira A. Anti-TIF1\u03b3-dermatomyositis and Sj\u00f6gren\u2019s syndrome as rectal cancer inaugural presentation. Cureus [Internet]. 2024, 16:e55978.","journal-title":"Cureus [Internet]"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2016.58756","article-title":"Clinical characteristics of patients with anti-TIF1-\u03b3 antibodies","volume":"54","author":"Masiak A","year":"2016","unstructured":"Masiak A, Kulczycka J, Czuszy\u0144ska Z, Zdrojewski Z. Clinical characteristics of patients with anti-TIF1-\u03b3 antibodies. Reumatologia. 2016, 54:14-8. 10.5114\/reum.2016.58756","journal-title":"Reumatologia"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-20-12-766","article-title":"Dropped head syndrome: etiology and management","volume":"20","author":"Sharan AD","year":"2012","unstructured":"Sharan AD, Kaye D, Charles Malveaux WM, Riew KD. Dropped head syndrome: etiology and management. J Am Acad Orthop Surg. 2012, 20:766-74. 10.5435\/JAAOS-20-12-766","journal-title":"J Am Acad Orthop Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrv055","article-title":"Early-onset dropped head syndrome after radiotherapy for head and neck cancer: dose constraints for neck extensor muscles","volume":"57","author":"Inaba K","year":"2016","unstructured":"Inaba K, Nakamura S, Okamoto H, et al.. Early-onset dropped head syndrome after radiotherapy for head and neck cancer: dose constraints for neck extensor muscles. J Radiat Res. 2016, 57:169-73. 10.1093\/jrr\/rrv055","journal-title":"J Radiat Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1267104","article-title":"Dropped head syndrome: diagnosis and management","volume":"2","author":"Martin AR","year":"2011","unstructured":"Martin AR, Reddy R, Fehlings MG. Dropped head syndrome: diagnosis and management. Evid Based Spine Care J. 2011, 2:41-7. 10.1055\/s-0030-1267104","journal-title":"Evid Based Spine Care J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20623","article-title":"Late appearance of dropped head syndrome after radiotherapy for Hodgkin's disease","volume":"34","author":"Rowin J","year":"2006","unstructured":"Rowin J, Cheng G, Lewis SL, Meriggioli MN. Late appearance of dropped head syndrome after radiotherapy for Hodgkin's disease. Muscle Nerve. 2006, 34:666-9. 10.1002\/mus.20623","journal-title":"Muscle Nerve"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/344886-paraneoplastic-anti-transcriptional-intermediary-factor-1-anti-tif1-positive-dermatomyositis-presenting-as-dropped-head-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:42:23Z","timestamp":1740501743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/344886-paraneoplastic-anti-transcriptional-intermediary-factor-1-anti-tif1-positive-dermatomyositis-presenting-as-dropped-head-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.79631","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}